Analysis of CLL progression in these mice showed that Eomes−/− CD4+ T cells failed to control CLL development as evidenced by higher numbers of CD5+ CD19+ CLL cells in blood and higher spleen weights (Fig. 5A). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.